How are gallbladder polyps treated?

Aug 22, 2026 Source: Cainiu Health
Dr. Gao Jun
Introduction
Gallbladder polyps can be managed systematically through lifestyle interventions, regular follow-up monitoring, choleretic and regulatory therapy, symptomatic anti-inflammatory treatment, and surgical intervention. The treatment plan is determined comprehensively based on polyp size, number, morphology, and associated systemic symptoms, following the principle of progressing from conservative, minimally invasive interventions to definitive, curative treatments. If recurrent right upper quadrant abdominal pain or rapid polyp enlargement occurs, prompt clinical evaluation is warranted.

Cholecystic polyps can be managed systematically through lifestyle modifications, regular follow-up monitoring, choleretic and regulatory therapy, symptomatic anti-inflammatory treatment, and surgical intervention. The treatment plan is determined comprehensively based on polyp size, number, morphology, and associated clinical symptoms, following the principle of progressing from conservative, minimally invasive interventions to definitive, curative treatment. Patients experiencing recurrent right upper quadrant abdominal pain or rapid polyp enlargement should seek timely medical evaluation and treatment.

1. Lifestyle Intervention: Maintain regular, balanced meals—especially ensuring breakfast—and avoid prolonged fasting to prevent bile stasis. Adjust dietary patterns by limiting high-fat and high-cholesterol foods; opt instead for light, low-fat meals. Incorporate moderate physical activity to maintain stable body weight and steady metabolic function, thereby reducing chronic stimulation of the gallbladder.

2. Regular Follow-up Monitoring: For small, morphologically regular polyps without associated symptoms, routine surveillance is the primary approach. Abdominal ultrasound examinations should be scheduled periodically to document changes in polyp size, morphology, and number. Polyps demonstrating long-term stability require no specific intervention—consistent follow-up alone suffices to mitigate malignant transformation risk.

3. Choleretic and Regulatory Therapy: When mild bile stasis or chronic cholecystitis coexists with polyps, choleretic therapy may be employed to promote bile flow and alleviate chronic mucosal irritation of the gallbladder. This improves the intra-gallbladder metabolic environment, reduces inflammation-induced mucosal hyperplasia, relieves mild systemic discomfort, and slows polyp growth.

4. Symptomatic Anti-inflammatory Treatment: In cases where cholecystic polyps are accompanied by acute cholecystitis, anti-inflammatory therapy is indicated to control local gallbladder inflammation and reduce mucosal congestion and edema. This helps alleviate symptoms such as abdominal pain and distension, prevents repeated inflammatory insults that could alter polyp morphology, and lowers the risk factors associated with malignant transformation.

5. Surgical Intervention: Surgery is recommended for polyps exhibiting large size, broad base, irregular morphology, or rapid growth over a short period. Cholecystectomy removes the diseased gallbladder entirely, eliminating the lesion, halting further progression, and preventing long-term malignant transformation—particularly appropriate for patients with high-risk cholecystic polyps.

Maintain a low-fat, light diet; avoid unhealthy habits such as staying up late or prolonged sitting; adhere to regular sleep-wake cycles and stable metabolism; undergo routine gallbladder-specific examinations; and adjust the treatment strategy promptly according to observed changes in the polyps.